SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001013594-20-000175
Filing Date
2020-02-14
Accepted
2020-02-14 15:19:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G marinus13g_12312019.htm SC 13G 319565
  Complete submission text file 0001013594-20-000175.txt   321128
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Subject) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88269 | Film No.: 20618635
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019 212-356-6200
Lion Point Capital, LP (Filed by) CIK: 0001643354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G